ARK Genomic Revolution ETF (ARKG)

Equity ETF · ARK

ARK Genomic Revolution ETF (ARKG) is an exchange traded fund from ARK that tracks the Active — genomic revolution thematic. The fund holds $1.56 billion in assets and charges an expense ratio of 0.75%. It launched on 2014-10-31. Its composition runs to 31 positions, the ten largest of which are listed below, as of 2026-09-18. SentiSense classifies it as an equity fund and tracks news coverage and holdings weighted sentiment for it. Full holdings, flows and per holding sentiment for ARKG are on the SentiSense fund page.

Issuer
ARK
Tracks
Active — genomic revolution thematic
Asset Class
Equity
Assets
$1.6B
Expense Ratio
0.75%
Inception
2014-10-31
Listed On
Cboe BZX
Holdings
31

Ten largest holdings

HoldingSymbolWeight
10X GENOMICS INC-CLASS ATXG9.46%
TEMPUS AI INC-CL ATEM9.23%
TWIST BIOSCIENCE CORPTWST9%
CRISPR THERAPEUTICS AGCRSP5.72%
PERSONALIS INCPSNL5.13%
GUARDANT HEALTH INCGH4.99%
ABSCI CORPABSI4.59%
ILLUMINA INCILMN4.24%
NATERA INCNTRA4.23%
CAREDX INCCDNA3.82%

Showing the ten largest of 31 positions, as of 2026-09-18.

Frequently asked questions

What does ARKG track?

ARK Genomic Revolution ETF tracks the Active — genomic revolution thematic. It is issued by ARK.

What is ARKG's expense ratio?

ARK Genomic Revolution ETF charges an expense ratio of 0.75%, which is the annual cost of holding the fund as a share of assets.

How big is ARKG?

ARK Genomic Revolution ETF holds $1.56 billion in assets under management, spread across 31 positions.

What are ARKG's largest holdings?

The largest positions in ARK Genomic Revolution ETF are 10X GENOMICS INC-CLASS A, TEMPUS AI INC-CL A and TWIST BIOSCIENCE CORP. Composition is as of 2026-09-18. The ten largest are listed on this page and the full composition is on the SentiSense fund page.

Full holdings, fund flows and holdings weighted sentiment for ARK Genomic Revolution ETF on SentiSense.